Related Experiment Video
Updated: Feb 25, 2026

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Clinical and microbiological characteristics of Pantoea agglomerans infection in children
Ayşe Büyükcam1, Özlem Tuncer2, Deniz Gür2
1Pediatric Infectious Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Abstract:
Pantoea agglomerans is an environmental Gram-negative bacterium that rarely is responsible for the infections in humans but it is often a causative factor of a number of occupational diseases. This study evaluated the clinical and microbiological characteristics and pathogenicity of P. agglomerans in children. We retrospectively reviewed microbiological test results for all children (1 month old to 18 years old) who were admitted to our pediatric hospital between January 2000 to June 2015 and had positive clinical specimen cultures for P. agglomerans. Isolates were identified using conventional tests and the BBL Crystal E/NF ID or MALDI-TOF MS systems. Antibiotic susceptibilities were evaluated using the Kirby-Bauer disc diffusion method. We identified fifteen positive cultures from 14 patients with confirmed infections. The positive specimens included pus, urine, tracheal aspirate, blood, and central venous line samples that yielded P. agglomerans. The median patient age was 8.8 years (range: 1.5 months to 16.5 years), and all patients had underlying comorbidities. Five patients had medical devices, and two devices were removed. The most common P. agglomerans infections involved wound infections (35.7%), pneumonia (21.4%), and urinary tract infections (21.4%). Three patients had concomitant infections (Enterococcus faecium, Pseudomonas aeruginosa, and Aspergillus fumigatus). Five patients had anemia. Three patients (21.4%) died, and all three had carbapenem-resistant P. agglomerans that was detected after the first week of hospitalization; two cases involved pneumonia, which was ineffectively treated. P. agglomerans infections may be life-threatening, especially in young patients with pneumonia. Hospital-acquired P. agglomerans may have different pathogenicity and clinical features, compared to community-acquired P. agglomerans, although further studies are needed to understand the drug-resistance patterns in this bacterium.
Insights
Pantoea agglomerans infections, though rare in children, can be severe, particularly pneumonia in those with comorbidities. Carbapenem-resistant strains are linked to mortality, highlighting the need for further research into drug resistance.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Clinical Bacteriology
Background:
- Pantoea agglomerans is an environmental Gram-negative bacterium.
- It rarely causes human infections but is linked to occupational diseases.
- Its role in pediatric infections is not well-defined.
Purpose of the Study:
- To evaluate the clinical and microbiological characteristics of Pantoea agglomerans infections in children.
- To assess the pathogenicity and outcomes of P. agglomerans in a pediatric population.
- To identify risk factors and common infection types associated with P. agglomerans.
Main Methods:
- Retrospective review of pediatric hospital records (January 2000-June 2015).
- Inclusion criteria: patients aged 1 month to 18 years with positive P. agglomerans cultures.
- Identification methods included conventional tests, BBL Crystal E/NF ID, and MALDI-TOF MS. Antibiotic susceptibility testing used the Kirby-Bauer method.
Main Results:
- Fifteen positive cultures from 14 pediatric patients were identified.
- Common infection sites included wound infections (35.7%), pneumonia (21.4%), and urinary tract infections (21.4%).
- Three patients (21.4%) died, all with carbapenem-resistant P. agglomerans, particularly in cases of pneumonia.
Conclusions:
- Pantoea agglomerans infections can be life-threatening in children, especially those with pneumonia and underlying comorbidities.
- Carbapenem resistance is a significant factor in mortality.
- Further research is needed to understand hospital-acquired P. agglomerans pathogenicity and drug-resistance patterns.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment

